Literature DB >> 20446435

The thyroid and autoimmunity.

Corina Lichiardopol1, Maria Moţa.   

Abstract

Autoimmune thyroid diseases (Hashimoto thyroiditis, Graves' disease, postpartum thyroiditis, atrophic thyroiditis and drug induced thyroiditis) are prevalent disorders worldwide, especially in women (related to the millieu of sex steroids and X chromosome effects on the thyroid and the immune system). Disruption of thyroid self tolerance, usually induced by an infection, generates abnormal thyroid--immune interactions, implicating an array of cytokines and their receptors. Thyrocytes achieve antigen presenting cell properties which stimulate effector immune cells (Th1, Th2, Th17), in the context of defective immunomodulatory T regulatory cells, resulting in thyroid lymphocytic infiltration and activation of B cells, with production of antibodies against thyroid antigens, thyroid destruction or stimulation, depending on the Th1-Th2 balance. During pregnancy there is a Th2 predominance sustained by the increased glucocorticoid, estrogen and progesteron levels, which allows tolerance versus the histoincompatible fetoplacental unit. In the postpartum period, the return shift Th2 to Th1 favors the occurrence of postpartum thyroiditis. Altered thyroid hormone levels can influence the immune system, and, on the other side, some immune cells secrete TSH, which exerts endocrine and paracrine, cytokine-like effects. Understanding the complex pathogenesis of autoimmune thyroid disorders is crucial for prevention and management.

Entities:  

Mesh:

Year:  2009        PMID: 20446435

Source DB:  PubMed          Journal:  Rom J Intern Med        ISSN: 1220-4749


  12 in total

1.  Thyroid dysfunction associated with administration of the long-acting gonadotropin-releasing hormone agonist.

Authors:  Eun Jin Han; Ha Do Song; Ji Hoon Yang; So Young Park; Sung Hoon Kim; Hyun Koo Yoon; Chang Hoon Yim
Journal:  Endocrinol Metab (Seoul)       Date:  2013-09-13

2.  Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves' hyperthyroidism.

Authors:  Jin Zhou; Mei Bi; Chenling Fan; Xizhu Song; Rong Yang; Shujie Zhao; Li Li; Yushu Li; Weiping Teng; Zhongyan Shan
Journal:  Clin Exp Med       Date:  2011-05-05       Impact factor: 3.984

Review 3.  Endocrine Autoimmunity in Pregnancy.

Authors:  Renata Świątkowska-Stodulska; Agata Berlińska; Katarzyna Stefańska; Maciej Zieliński; Sebastian Kwiatkowski; Joanna Połom; Elżbieta Andrysiak-Mamos; Piotr Wydra; Krzysztof Sworczak
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

4.  Immunological changes of T helper cells in flow cytometer-sorted CD4+ T cells from patients with Hashimoto's thyroiditis.

Authors:  Yanying Guo; Jazyra Zynat; Shuqing Xing; Liang Xin; Suli Li; Nurongguli Mammat; Yuan Chen; Limin Zhao; Hongli Zhao; Xinling Wang
Journal:  Exp Ther Med       Date:  2018-02-01       Impact factor: 2.447

5.  Coincidence of remission of postpartum Graves' disease and use of omega-3 fatty acid supplements.

Authors:  Sarah J Breese McCoy
Journal:  Thyroid Res       Date:  2011-11-16

6.  Cytometric evaluation of intracellular IFN-γ and IL-4 levels in thyroid follicular cells from patients with autoimmune thyroid diseases.

Authors:  Artur Bossowski; Jerzy Harasymczuk; Anna Moniuszko; Anna Bossowska; Maciej Hilczer; Karol Ratomski
Journal:  Thyroid Res       Date:  2011-09-23

7.  THE EFFECT OF ANTITHYROID DRUGS ON OSTEOPONTIN AND OXIDATIVE STRESS IN GRAVES' DISEASE.

Authors:  M Kocak; E Akarsu; H Korkmaz; S Taysi
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

8.  Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves' disease.

Authors:  Xinxin Chen; Yanqiu Wang; Yicheng Qi; Jiqi Yan; Fengjiao Huang; Mengxi Zhou; Weiqing Wang; Guang Ning; Yulin Zhou; Shu Wang
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

9.  Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance.

Authors:  Matteo Martino; Giulio Rocchi; Andrea Escelsior; Michele Fornaro
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363

10.  Chemokine (C-C motif) ligand 20, a potential biomarker for Graves' disease, is regulated by osteopontin.

Authors:  Xiaoli Li; Yicheng Qi; Xinran Ma; Fengjiao Huang; Hua Guo; Xiaohua Jiang; Jie Hong; Dongping Lin; Bin Cui; Guang Ning; Lingyan Xu; Shu Wang
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.